| 4XCU: reference: First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway., Hagel M, Miduturu C, Sheets M, Rubin N, Weng W, Stransky N, Bifulco N, Kim JL, Hodous B, Brooijmans N, Shutes A, Winter C, Lengauer C, Kohl NE, Guzi T, Cancer Discov. 2015 Mar 16. PMID: 25776529 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).